Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration

Purpose: The formation of macular hole after receiving anti-vascular endothelial growth factor (anti-VEGF) therapy is rare. We report a case of macular hole that occurred after intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD) in a patient, who underwent vitrect...

Full description

Bibliographic Details
Main Authors: Akira Hirata, Ken Hayashi, Kazuhisa Murata, Kei-ichiro Nakamura
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S245199361730172X
_version_ 1818929567629312000
author Akira Hirata
Ken Hayashi
Kazuhisa Murata
Kei-ichiro Nakamura
author_facet Akira Hirata
Ken Hayashi
Kazuhisa Murata
Kei-ichiro Nakamura
author_sort Akira Hirata
collection DOAJ
description Purpose: The formation of macular hole after receiving anti-vascular endothelial growth factor (anti-VEGF) therapy is rare. We report a case of macular hole that occurred after intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD) in a patient, who underwent vitrectomy combined with choroidal neovascularization (CNV) removal. Observations: A 64-year-old female with AMD affecting her right eye received an intravitreal injection of an anti-VEGF agent. After treatment, we identified a full thickness macular hole (MH) that was associated with the rapid resolution of the macular edema and contraction of the CNV. After performing vitrectomy combined with CNV removal, the MH closed and her visual acuity improved. Examination of the removed CNV revealed a network of microvessels devoid of pericytes. Conclusions and importance: The present findings suggest that rapid resolution of macular edema and contraction of the CNV and/or mild increase in the vitreous traction after anti-VEGF therapy could potentially cause MH. CNV removal via the MH may be an acceptable procedure, if the MH remains open, the CNV is of the classic type, and it spares a central portion of the fovea.
first_indexed 2024-12-20T03:46:51Z
format Article
id doaj.art-bbd2266b93084875bdba4a85507df9e6
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-12-20T03:46:51Z
publishDate 2018-03-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-bbd2266b93084875bdba4a85507df9e62022-12-21T19:54:36ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362018-03-019C141710.1016/j.ajoc.2017.12.003Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degenerationAkira Hirata0Ken Hayashi1Kazuhisa Murata2Kei-ichiro Nakamura3Hayashi Eye Hospital, Fukuoka, JapanHayashi Eye Hospital, Fukuoka, JapanDepartment of Ophthalmology, Saga University Faculty of Medicine, Saga, JapanDivision of Microscopic and Developmental Anatomy, Department of Anatomy, Kurume University School of Medicine, Kurume, JapanPurpose: The formation of macular hole after receiving anti-vascular endothelial growth factor (anti-VEGF) therapy is rare. We report a case of macular hole that occurred after intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD) in a patient, who underwent vitrectomy combined with choroidal neovascularization (CNV) removal. Observations: A 64-year-old female with AMD affecting her right eye received an intravitreal injection of an anti-VEGF agent. After treatment, we identified a full thickness macular hole (MH) that was associated with the rapid resolution of the macular edema and contraction of the CNV. After performing vitrectomy combined with CNV removal, the MH closed and her visual acuity improved. Examination of the removed CNV revealed a network of microvessels devoid of pericytes. Conclusions and importance: The present findings suggest that rapid resolution of macular edema and contraction of the CNV and/or mild increase in the vitreous traction after anti-VEGF therapy could potentially cause MH. CNV removal via the MH may be an acceptable procedure, if the MH remains open, the CNV is of the classic type, and it spares a central portion of the fovea.http://www.sciencedirect.com/science/article/pii/S245199361730172XMacular holeVitrectomyChoroidal neovascular membraneAge-related macular degenerationFIB/SEM
spellingShingle Akira Hirata
Ken Hayashi
Kazuhisa Murata
Kei-ichiro Nakamura
Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
American Journal of Ophthalmology Case Reports
Macular hole
Vitrectomy
Choroidal neovascular membrane
Age-related macular degeneration
FIB/SEM
title Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
title_full Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
title_fullStr Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
title_full_unstemmed Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
title_short Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
title_sort removal of choroidal neovascular membrane in a case of macular hole after anti vegf therapy for age related macular degeneration
topic Macular hole
Vitrectomy
Choroidal neovascular membrane
Age-related macular degeneration
FIB/SEM
url http://www.sciencedirect.com/science/article/pii/S245199361730172X
work_keys_str_mv AT akirahirata removalofchoroidalneovascularmembraneinacaseofmacularholeafterantivegftherapyforagerelatedmaculardegeneration
AT kenhayashi removalofchoroidalneovascularmembraneinacaseofmacularholeafterantivegftherapyforagerelatedmaculardegeneration
AT kazuhisamurata removalofchoroidalneovascularmembraneinacaseofmacularholeafterantivegftherapyforagerelatedmaculardegeneration
AT keiichironakamura removalofchoroidalneovascularmembraneinacaseofmacularholeafterantivegftherapyforagerelatedmaculardegeneration